Details for 2020726959

Up to date per 05.04.2026

Actions

Title / Product Name

KRISTALLINE FORMEN VON N-[4-(CHLORDIFLUORMETHOXY)PHENYL]-6-[(3R)-3-HYDROXYPYRROLIDIN-1-YL] -5-( 1H-PYRAZOL-5-YL) PYRIDIN-3-CARBOXAMID

Status

Granted/Registered

Protection Type

European Patent

(AT-) Application Number

2020726959

EP Publication Number

3969117

E-Number

1900950

Language

PCT Number

IB20054628

Publication Date

23.03.2022 A

25.03.2026 B1

Registration Date

25.03.2026

AT Publication Date

15.04.2026

Application Date

15.05.2020

Registration Number

Priorities

16.05.2019

201962848857 P

18.12.2019

201962949599 P

IPC

A61P 35/00 20060101AFI20201120BHEP

Maximum Duration of Protection

15.05.2040

Owner

Novartis AGLichtstrasse 35 4056 BaselCH

Representative

No representatives present

Inventor

DODD, Stephanie Kayc/o Novartis Institutes for Bio Medical Research, Inc., 250 Massachusetts Avenue, Cambridge, New Jersey 02139US

GRANDEURY, Arnaudc/o Novartis Pharma AG Postfach 4002 BaselCH

ROUSAKI, Evgeniac/o Novartis Pharma AG Postfach 4002 BaselCH

SUFFERT, Emmanuelc/o Novartis Pharma AG Postfach 4002 BaselCH

Information about Fees